There is an urgent need for therapies to treat or prevent devastating viral diseases in immunocompromised patients with T cell deficiencies who have limited or no treatment options.
We develop allogeneic, off-the-shelf virus-specific T cell (VST) therapy candidates designed to treat or prevent life-threatening viral diseases.
AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?